Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
92.01
-2.43 (-2.57%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, Edwards Lifesciences stock has a consensus rating of "Buy" and an average price target of $101.87. The average 1-year stock price forecast is 10.72% higher than the current stock price, while the lowest is $84 (-8.71%) and the highest is $117 (+27.16%).
Price Target: $101.87 (+10.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 18 | 18 | 18 | 18 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 8 | 8 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 29 | 29 | 29 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Reiterates $104 | Buy | Reiterates | $104 | +13.03% | Oct 27, 2026 |
| Citi | Citi | Buy Maintains $110 | Buy | Maintains | $110 | +19.55% | Oct 22, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $100 → $101 | Buy | Reiterates | $100 → $101 | +9.77% | Oct 15, 2026 |
| BTIG | BTIG | Buy Reiterates $110 | Buy | Reiterates | $110 | +19.55% | Oct 9, 2026 |
| UBS | UBS | Buy Maintains $110 | Buy | Maintains | $110 | +19.55% | Oct 8, 2026 |
Financial Forecast
Revenue This Year
6.76B
from 6.07B
Increased by 11.43%
Revenue Next Year
7.43B
from 6.76B
Increased by 9.91%
EPS This Year
3.00
from 2.56
Increased by 17.17%
EPS Next Year
3.38
from 3.00
Increased by 12.71%
EPS and Forward PE are based on non-GAAP adjusted numbers.